|
gptkbp:instanceOf
|
gptkb:COVID-19
|
|
gptkbp:alsoKnownAs
|
gptkb:Kraken
|
|
gptkbp:descendedFrom
|
gptkb:Omicron_variant
XBB variant
|
|
gptkbp:discoveredBy
|
gptkb:United_States
October 2022
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
XBB.1.5 variant
|
|
gptkbp:lineage
|
XBB lineage
|
|
gptkbp:mutationAssociatedWith
|
gptkb:F486P
S486P
|
|
gptkbp:notableFor
|
gptkb:GISAID
gptkb:World_Health_Organization
gptkb:UK_Health_Security_Agency
gptkb:European_Centre_for_Disease_Prevention_and_Control
gptkb:US_Centers_for_Disease_Control_and_Prevention
gptkb:Nextstrain
immune evasion
high transmissibility
Indian SARS-CoV-2 Genomics Consortium
increased ACE2 binding affinity
CoVariants.org
potential for increased infectivity
potential to cause reinfections
potential to reduce vaccine effectiveness
rapid growth in US in late 2022
|
|
gptkbp:PANGOlineage
|
gptkb:XBB.1.5
|
|
gptkbp:parentVariant
|
gptkb:XBB
gptkb:Omicron
|
|
gptkbp:relatedTo
|
gptkb:BA.2
gptkb:BA.5
gptkb:XBB.1
gptkb:BQ.1
gptkb:BA.2.75
BA.2.10.1
XBB.1.16
BQ.1.1
XBB.1.9
Omicron subvariants
|
|
gptkbp:spreadTo
|
gptkb:Asia
gptkb:Australia
gptkb:Canada
gptkb:Europe
gptkb:India
gptkb:United_Kingdom
|
|
gptkbp:subclassOf
|
gptkb:XBB
gptkb:Omicron
|
|
gptkbp:WHOClassification
|
Variant of Interest
|
|
gptkbp:bfsParent
|
gptkb:COVID-19
|
|
gptkbp:bfsLayer
|
4
|